Victory Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170M Sell
2,171,583
-1,107,822
-34% -$89.4M 0.1% 224
2026
Q1
$247M Buy
3,279,405
+1,660,621
+103% +$159M 0.16% 163
2025
Q4
$156M Sell
1,618,784
-10,671
-0.7% -$1.04M 0.09% 217
2025
Q3
$155M Sell
1,629,455
-354,230
-18% -$32.6M 0.09% 209
2025
Q2
$173M Buy
1,983,685
+245,106
+14% +$20.8M 0.11% 202
2025
Q1
$156M Sell
1,738,579
-180,097
-9% -$16.1M 0.16% 141
2024
Q4
$153M Sell
1,918,676
-39,745
-2% -$3.44M 0.15% 144
2024
Q3
$176M Buy
1,958,421
+313,525
+19% +$26.4M 0.17% 131
2024
Q2
$129M Buy
1,644,896
+36,467
+2% +$2.99M 0.13% 171
2024
Q1
$140M Buy
1,608,429
+90,912
+6% +$7.76M 0.14% 162
2023
Q4
$125M Sell
1,517,517
-59,032
-4% -$4.5M 0.13% 179
2023
Q3
$124M Sell
1,576,549
-42,978
-3% -$3.6M 0.14% 156
2023
Q2
$143M Sell
1,619,527
-212,948
-12% -$18.3M 0.16% 138
2023
Q1
$148M Buy
1,832,475
+361,961
+25% +$29.5M 0.17% 134
2022
Q4
$114M Sell
1,470,514
-82,276
-5% -$6.67M 0.13% 187
2022
Q3
$125M Buy
1,552,790
+797,869
+106% +$71.7M 0.15% 166
2022
Q2
$67.8M Buy
754,921
+32,147
+4% +$3.26M 0.08% 343
2022
Q1
$79.1M Sell
722,774
-32,224
-4% -$3.4M 0.08% 330
2021
Q4
$78.1M Buy
754,998
+13,641
+2% +$1.58M 0.07% 376
2021
Q3
$92.9M Buy
741,357
+106,180
+17% +$13.7M 0.09% 293
2021
Q2
$78.8M Buy
635,177
+139,936
+28% +$17.6M 0.08% 372
2021
Q1
$58.5M Buy
495,241
+120,028
+32% +$14.1M 0.06% 474
2020
Q4
$44M Buy
375,213
+125,691
+50% +$13.8M 0.05% 558
2020
Q3
$25.9M Sell
249,522
-64,180
-20% -$6.45M 0.03% 680
2020
Q2
$28.8M Sell
313,702
-357,260
-53% -$34.3M 0.04% 635
2020
Q1
$60.5M Buy
670,962
+49,135
+8% +$5.23M 0.1% 283
2019
Q4
$70.5M Buy
621,827
+49,917
+9% +$5.48M 0.09% 343
2019
Q3
$62.1M Buy
571,910
+459,193
+407% +$47.9M 0.08% 365
2019
Q2
$11M Buy
112,717
+2,950
+3% +$269K 0.02% 764
2019
Q1
$10M Buy
109,767
+43,244
+65% +$3.87M 0.02% 737
2018
Q4
$6.05M Buy
66,523
+46,476
+232% +$4.34M 0.02% 794
2018
Q3
$1.97M Sell
20,047
-451
-2% -$41.7K ﹤0.01% 1101
2018
Q2
$1.75M Sell
20,498
-426
-2% -$35.6K ﹤0.01% 1103
2018
Q1
$1.68M Sell
20,924
-6,595
-24% -$544K ﹤0.01% 1113
2017
Q4
$2.22M Sell
27,519
-119,838
-81% -$9.6M ﹤0.01% 999
2017
Q3
$11.5M Sell
147,357
-7,202
-5% -$598K 0.03% 701
2017
Q2
$13.7M Sell
154,559
-196,293
-56% -$16.6M 0.03% 657
2017
Q1
$28.3M Sell
350,852
-113,915
-25% -$8.9M 0.07% 486
2016
Q4
$33.1M Sell
464,767
-209,845
-31% -$16.5M 0.08% 419
2016
Q3
$58.3M Sell
674,612
-132,185
-16% -$11.5M 0.16% 209
2016
Q2
$70M Sell
806,797
-3,191
-0.4% -$258K 0.28% 112
2016
Q1
$60.7M Sell
809,988
-128,038
-14% -$9.64M 0.25% 125
2015
Q4
$72.2M Sell
938,026
-226,843
-19% -$17.1M 0.3% 99
2015
Q3
$78M Sell
1,164,869
-1,692,485
-59% -$125M 0.32% 88
2015
Q2
$212M Buy
2,857,354
+982,882
+52% +$75.1M 0.78% 5
2015
Q1
$146M Buy
1,874,472
+266,015
+17% +$20.2M 0.53% 30
2014
Q4
$116M Buy
1,608,457
+825,977
+106% +$57.4M 0.43% 57
2014
Q3
$48.5M Buy
+782,480
New +$49.8M 0.37% 74
2014
Q2
Sell
-1,490
Closed -$92K 903
2014
Q1
$92K Buy
+1,490
New +$86.8K ﹤0.01% 705
2013
Q4
Sell
-252
Closed -$13K 1041
2013
Q3
$13K Buy
+252
New +$13.6K ﹤0.01% 999

Other funds holding MDT

Victory Capital Management's MDT Position: Q2 2026 in Review

Victory Capital Management reduced its Medtronic (MDT) stake by 34% in Q2 2026, selling an estimated $89.4M and leaving 2,171,583 shares worth $170M. The position accounts for 0.1% of the portfolio, ranked #224.

Victory Capital Management first reported a position in MDT in Q3 2013 and has held it in 50 quarters since. The position peaked at $247M in Q1 2026. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Victory Capital Management held 2,171,583 shares of Medtronic worth $170M as of Q2 2026.
  • Victory Capital Management sold 1,107,822 Medtronic shares in Q2 2026, an estimated $89.4M.
  • Medtronic made up 0.1% of Victory Capital Management's portfolio in Q2 2026, its #224 holding.
  • Victory Capital Management first reported a position in Medtronic in Q3 2013 and has held it in 50 quarters since.
  • Victory Capital Management's Medtronic position peaked at $247M in Q1 2026.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.